Kezar Life Sciences CEO John Fowler's 2021 pay jumps 346% to $5.6M
Kezar Life Sciences reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Kezar Life Sciences reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, three executives at Kezar Life Sciences received on average a compensation package of $3M, a 154% increase compared to previous year.
Average pay of disclosed executives at Kezar Life Sciences
John Fowler, Chief Executive Officer, received $5.6M in total, which increased by 346% compared to 2020. 84% of Fowler's compensation, or $4.7M, was in option awards. Fowler also received $326K in non-equity incentive plan, $567K in salary, as well as $12K in other compensation.
Noreen Roth Henig, Chief Medical Officer, received a compensation package of $1.8M, which increased by 24% compared to previous year. 61% of the compensation package, or $1.1M, was in option awards.
Christopher Kirk, Chief Scientific Officer, earned $1.7M in 2021, a 92% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2022.